Resources
483 Results (showing 181 - 190)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 3/7/2023 (updated 3/27/2024)
Training material Pre-Addiction: Research Needed to Evaluate its Public Health Value
Posted 3/21/2023 (updated 3/27/2024)
Training materials A Stimulating Talk
Posted 2/28/2023 (updated 3/27/2024)
Harm in Behavioral Health: The Ethical Necessity for Multicultural Practices in Behavioral Health Programs webinar training material.
Posted 3/14/2023 (updated 3/27/2024)
The Drug Enforcement Administration (DEA) announced proposed rules for the prescribing of controlled medications via telemedicine beyond the end of the COVID-19 public health emergency. One rule addresses the expansion of induction of buprenorphine via telemedicine encounter while the other covers telemedicine prescribing of controlled substances when the practitioner and the patient have not had a prior in-person medical evaluation. While opioid use disorders occur at similar rates in both rural and urban areas, medication assisted treatment (MAT) prescribers have been disproportionately located in urban areas. The public will be able to comment on the proposed rules until March 31st.
Posted 3/14/2023 (updated 3/27/2024)
Xylazine is a non-opioid that is approved for animals, and not FDA-approved for humans. New York State's Department of Health provides information on what it is, sources and trends, effects, why people use it, why clinicians should be concerned, and other information on Xylazine. Information about Xylazine is important to understand now that it has been showing up in illicit drug supply.
Posted 9/7/2022 (updated 3/27/2024)
During this webinar, Claudia Jasso, Chief Development Officer for RCORP Implementation grantee, Amistades, Inc. and Janet Ojeda, JBS International Technical Expert Lead will present an overview of the unique cultural context, core beliefs, and value systems that should be at the heart of understanding and engaging with Latino populations. Presenters will discuss how racial inequity, assimilation, risk factors, and historical and immigration trauma have created a landscape where there is a critical need for person centered, culturally respectful and relevant mental health and SUD/OUD supports and service delivery for Latino people. All RCORP grantees, consortium members, and key community partners are welcome to attend.
Posted 9/6/2022 (updated 3/27/2024)
On Monday, the U.S. Department of Health & Human services announced approximately $4 million to four awardees through its Rural Maternity and Obstetrics Management Strategies Program to enhance access to and coordination of obstetric and maternal care in rural communities.
Posted 8/23/2022 (updated 3/27/2024)
This observational study of 719 612 pharmacy claims data shows that OOP costs of naloxone grew substantially beginning in 2016. However, OOP costs did not increase for all patients and all brands of naloxone but primarily for uninsured patients and for the Evzio brand. The findings suggest that the OOP cost of naloxone has been an increasingly substantial barrier to naloxone access for uninsured patients, a population that constitutes nearly one-fifth of adults with opioid use disorder.
Posted 8/17/2022 (updated 3/27/2024)
This presentation will detail the efforts behind the grant to develop a Recovery Friendly Workplace credential through training, technical assistance, and support that assists businesses in fostering a workplace culture that promotes employee safety, health, and well-being.
Posted 7/27/2022 (updated 3/27/2024)
This presentation will focus on the relationship between trauma and substance use as it relates to treatment for women, as well as a discussion of impactful trauma-informed and gender-responsive interventions. The evidence-based interventions will be based on Seeking Safety and Finding Your Best Self models, both of which are present-focused and easily implemented in any treatment setting.